Dissect-BP: Digital Home Blood Pressure Monitoring in Type B Aortic Dissection Patients
Study Details
Study Description
Brief Summary
The primary objective of this study is to determine the effectiveness of home digital blood pressure monitoring in aiding providers to maintain blood pressure within a therapeutic range in type B aortic dissection patients upon discharge from the hospital.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Patients admitted to the Cleveland Clinic Main Campus with a diagnosis of type B aortic dissection or intramural hematoma who do not receive a surgical intervention during their index hospitalization, or planned intervention on follow up, and are discharged on medical therapy consisting of strict heart rate control and BP control will be included in the study. They will be either randomized to standard therapy to measure BP at home (standard of care) or intervention arm consisting of Withings Wireless Blood Pressure Monitor, which will transmit BP recordings from smartphone to MyChart/EPIC (test arm). All patients will first receive a 24 hour ambulatory monitor regardless of treatment assignment to establish baseline BP pattern. Following this patients randomized to intervention arm will utilize their Withings Blood Pressure Monitor. Providers on the study team will then adjust the patient's hypertensive medications to ensure their BP is below a systolic goal of 120 mmHg utilizing downloaded recordings available in the electronic medical record.
The primary clinical endpoint is the change in mean 24 hour systolic blood pressure between the start of the study and the end of the study period (4-week period). Secondary outcomes will include the number of patients able to achieve a therapeutic systolic blood pressure of 120 mmHg with both mean BP cuff and in office visit at end of 4 week period, increase in size as measured by computed tomography (CT) scan of the aorta, hospitalization or emergency room (ER) visits for symptoms from dissection or uncontrolled hypertension, hospitalization or ER visits for hypotension, all-cause mortality, and need for surgical intervention (open or endovascular).
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Intervention Group (digital BP monitoring) This group will receive a Withings digital BP monitor to transmit recordings to the study team who will make medication adjustments. |
Device: Withings Digital Blood Pressure Monitor
This is a home digital blood pressure monitor that can transmit recordings via a user's smartphone.
|
No Intervention: Standard of care BP monitoring This group will use a standard BP cuff and record and transmit data to their medical team as instructed by their providers or if they are concerned. |
Outcome Measures
Primary Outcome Measures
- Systolic Blood Pressure at End of 4 Weeks [4 weeks]
Systolic Blood Pressure at end of 4 weeks as measured by 24 hour ambulatory cuff.
Secondary Outcome Measures
- Mortality [4 weeks]
Individual incidence of death
- Surgical Intervention [4 weeks]
Surgical intervention (open or endovascular)
- Hospitalization or Emergency Room Visit for Uncontrolled Hypertension or Symptoms From Dissection [4 weeks]
Individual occurrence of hospitalization or Emergency Room visit for uncontrolled hypertension or symptoms from dissection
- Hospitalization or Emergency Room Visit for Hypotension [4 weeks]
Individual occurrence of hospitalization or Emergency Room visit for Hypotension
- Increase in Size or Progression of Dissection as Measured on Cardiac CT [4 weeks]
Incidence of Increase in size or progression of dissection compared to baseline as measured on cardiac CT
- Questionnaire Describing Patient Experience in the Study [4 weeks]
Collection of answers to questionnaire describing patient experience in the study
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients discharged from Cleveland Clinic Main Campus with principal diagnosis of type B aortic dissection (defined as distal from left subclavian artery) who do not receive a surgical intervention during their hospitalization
-
Arm Circumference of 9-17 inches
Exclusion Criteria:
- Patients who do not have a smart phone
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Cleveland Clinic | Cleveland | Ohio | United States | 44195 |
Sponsors and Collaborators
- The Cleveland Clinic
Investigators
- Principal Investigator: Venugopal Menon, M. D., The Cleveland Clinic
Study Documents (Full-Text)
More Information
Publications
None provided.- 19-723
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Standard of Care BP Monitoring | Intervention Group (Digital BP Monitoring) |
---|---|---|
Arm/Group Description | This group will use a standard BP cuff and record and transmit data to their medical team as instructed by their providers or if they are concerned. | This group will receive a Withings digital BP monitor to transmit recordings to the study team who will make medication adjustments. Withings Digital Blood Pressure Monitor: This is a home digital blood pressure monitor that can transmit recordings via a user's smartphone. |
Period Title: Overall Study | ||
STARTED | 3 | 1 |
COMPLETED | 1 | 1 |
NOT COMPLETED | 2 | 0 |
Baseline Characteristics
Arm/Group Title | Intervention Group (Digital BP Monitoring) | Standard of Care BP Monitoring | Total |
---|---|---|---|
Arm/Group Description | This group will receive a Withings digital BP monitor to transmit recordings to the study team who will make medication adjustments. Withings Digital Blood Pressure Monitor: This is a home digital blood pressure monitor that can transmit recordings via a user's smartphone. | This group will use a standard BP cuff and record and transmit data to their medical team as instructed by their providers or if they are concerned. | Total of all reporting groups |
Overall Participants | 1 | 3 | 4 |
Age (Count of Participants) | |||
<=18 years |
0
0%
|
0
0%
|
0
0%
|
Between 18 and 65 years |
1
100%
|
3
100%
|
4
100%
|
>=65 years |
0
0%
|
0
0%
|
0
0%
|
Sex: Female, Male (Count of Participants) | |||
Female |
1
100%
|
2
66.7%
|
3
75%
|
Male |
0
0%
|
1
33.3%
|
1
25%
|
Race and Ethnicity Not Collected (Count of Participants) | |||
Count of Participants [Participants] |
0
0%
|
Outcome Measures
Title | Systolic Blood Pressure at End of 4 Weeks |
---|---|
Description | Systolic Blood Pressure at end of 4 weeks as measured by 24 hour ambulatory cuff. |
Time Frame | 4 weeks |
Outcome Measure Data
Analysis Population Description |
---|
Study terminated prematurely due to COVID-19 pandemic; no analysis was performed. |
Arm/Group Title | Standard of Care BP Monitoring | Intervention Group (Digital BP Monitoring) |
---|---|---|
Arm/Group Description | This group will use a standard BP cuff and record and transmit data to their medical team as instructed by their providers or if they are concerned. | This group will receive a Withings digital BP monitor to transmit recordings to the study team who will make medication adjustments. Withings Digital Blood Pressure Monitor: This is a home digital blood pressure monitor that can transmit recordings via a user's smartphone. |
Measure Participants | 0 | 0 |
Title | Mortality |
---|---|
Description | Individual incidence of death |
Time Frame | 4 weeks |
Outcome Measure Data
Analysis Population Description |
---|
Study terminated prematurely due to COVID-19 pandemic; no analysis has been performed. |
Arm/Group Title | Standard of Care BP Monitoring | Intervention Group (Digital BP Monitoring) |
---|---|---|
Arm/Group Description | This group will use a standard BP cuff and record and transmit data to their medical team as instructed by their providers or if they are concerned. | This group will receive a Withings digital BP monitor to transmit recordings to the study team who will make medication adjustments. Withings Digital Blood Pressure Monitor: This is a home digital blood pressure monitor that can transmit recordings via a user's smartphone. |
Measure Participants | 0 | 0 |
Title | Surgical Intervention |
---|---|
Description | Surgical intervention (open or endovascular) |
Time Frame | 4 weeks |
Outcome Measure Data
Analysis Population Description |
---|
Study terminated prematurely due to COVID-19 pandemic; no analysis has been performed. |
Arm/Group Title | Standard of Care BP Monitoring | Intervention Group (Digital BP Monitoring) |
---|---|---|
Arm/Group Description | This group will use a standard BP cuff and record and transmit data to their medical team as instructed by their providers or if they are concerned. | This group will receive a Withings digital BP monitor to transmit recordings to the study team who will make medication adjustments. Withings Digital Blood Pressure Monitor: This is a home digital blood pressure monitor that can transmit recordings via a user's smartphone. |
Measure Participants | 0 | 0 |
Title | Hospitalization or Emergency Room Visit for Uncontrolled Hypertension or Symptoms From Dissection |
---|---|
Description | Individual occurrence of hospitalization or Emergency Room visit for uncontrolled hypertension or symptoms from dissection |
Time Frame | 4 weeks |
Outcome Measure Data
Analysis Population Description |
---|
Study terminated prematurely due to COVID-19 pandemic; no analysis has been performed. |
Arm/Group Title | Standard of Care BP Monitoring | Intervention Group (Digital BP Monitoring) |
---|---|---|
Arm/Group Description | This group will use a standard BP cuff and record and transmit data to their medical team as instructed by their providers or if they are concerned. | This group will receive a Withings digital BP monitor to transmit recordings to the study team who will make medication adjustments. Withings Digital Blood Pressure Monitor: This is a home digital blood pressure monitor that can transmit recordings via a user's smartphone. |
Measure Participants | 0 | 0 |
Title | Hospitalization or Emergency Room Visit for Hypotension |
---|---|
Description | Individual occurrence of hospitalization or Emergency Room visit for Hypotension |
Time Frame | 4 weeks |
Outcome Measure Data
Analysis Population Description |
---|
Study terminated prematurely due to COVID-19 pandemic; no analysis has been performed. |
Arm/Group Title | Standard of Care BP Monitoring | Intervention Group (Digital BP Monitoring) |
---|---|---|
Arm/Group Description | This group will use a standard BP cuff and record and transmit data to their medical team as instructed by their providers or if they are concerned. | This group will receive a Withings digital BP monitor to transmit recordings to the study team who will make medication adjustments. Withings Digital Blood Pressure Monitor: This is a home digital blood pressure monitor that can transmit recordings via a user's smartphone. |
Measure Participants | 0 | 0 |
Title | Increase in Size or Progression of Dissection as Measured on Cardiac CT |
---|---|
Description | Incidence of Increase in size or progression of dissection compared to baseline as measured on cardiac CT |
Time Frame | 4 weeks |
Outcome Measure Data
Analysis Population Description |
---|
Study terminated prematurely due to COVID-19 pandemic; no analysis has been performed. |
Arm/Group Title | Standard of Care BP Monitoring | Intervention Group (Digital BP Monitoring) |
---|---|---|
Arm/Group Description | This group will use a standard BP cuff and record and transmit data to their medical team as instructed by their providers or if they are concerned. | This group will receive a Withings digital BP monitor to transmit recordings to the study team who will make medication adjustments. Withings Digital Blood Pressure Monitor: This is a home digital blood pressure monitor that can transmit recordings via a user's smartphone. |
Measure Participants | 0 | 0 |
Title | Questionnaire Describing Patient Experience in the Study |
---|---|
Description | Collection of answers to questionnaire describing patient experience in the study |
Time Frame | 4 weeks |
Outcome Measure Data
Analysis Population Description |
---|
Study terminated prematurely due to COVID-19 pandemic; no analysis has been performed. |
Arm/Group Title | Standard of Care BP Monitoring | Intervention Group (Digital BP Monitoring) |
---|---|---|
Arm/Group Description | This group will use a standard BP cuff and record and transmit data to their medical team as instructed by their providers or if they are concerned. | This group will receive a Withings digital BP monitor to transmit recordings to the study team who will make medication adjustments. Withings Digital Blood Pressure Monitor: This is a home digital blood pressure monitor that can transmit recordings via a user's smartphone. |
Measure Participants | 0 | 0 |
Adverse Events
Time Frame | 2 weeks and 4 weeks | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Standard of Care BP Monitoring | Intervention Group (Digital BP Monitoring) | ||
Arm/Group Description | This group will use a standard BP cuff and record and transmit data to their medical team as instructed by their providers or if they are concerned. | This group will receive a Withings digital BP monitor to transmit recordings to the study team who will make medication adjustments. Withings Digital Blood Pressure Monitor: This is a home digital blood pressure monitor that can transmit recordings via a user's smartphone. | ||
All Cause Mortality |
||||
Standard of Care BP Monitoring | Intervention Group (Digital BP Monitoring) | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/3 (0%) | 0/1 (0%) | ||
Serious Adverse Events |
||||
Standard of Care BP Monitoring | Intervention Group (Digital BP Monitoring) | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/3 (0%) | 0/1 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Standard of Care BP Monitoring | Intervention Group (Digital BP Monitoring) | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/3 (0%) | 0/1 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Venu Menon, M. D. |
---|---|
Organization | Cleveland Clinic |
Phone | 216-445-5390 |
menonv@ccf.org |
- 19-723